ITC — Deck

ITC Limited · ITC · NSE

India's most profitable conglomerate trades at 18x earnings — cigarette trap or FMCG breakout?

₹307
CMP
₹3.84L Cr
Market Cap
18.6x
P/E Ratio
36.8%
ROCE
Near 52-week low (₹287), FIIs shed 7pp since Mar 2023, Feb 2026 cigarette tax hike looms over Q4
1 · Business

A 59%-margin cigarette monopoly funding a ₹6,000 Cr FMCG empire

  • Cigarettes — ₹8,791 Cr revenue at 59% PBIT margin; the cash engine funding all diversification, but illicit trade already captures a third of the market.
  • FMCG-Others — ₹6,020 Cr across Aashirvaad, Sunfeast, Bingo; margins recovered to 10% EBITDA, the proof-point that scale is converting to profit.
  • Agri & Paper — Agri (₹3,560 Cr) supplies raw materials in a vertically integrated loop; Paperboards (₹2,202 Cr, 9% margin) is a chronic drag facing Chinese dumping.
The moat is capital allocation: converting tobacco cash into consumer brands at 36.8% group ROCE.
2 · Numbers

Fortress balance sheet, widening peer discount, and a dividend that pays you to wait

18.6x
P/E (peers at 42-79x)
4.75%
Div Yield (peers 1-1.8%)
28%
Avg FCF Margin (10-year)
₹2,850 Cr
Total Debt (net cash)

ITC generates ₹15,500+ Cr annual FCF on a net-cash balance sheet, yet trades at less than half any FMCG peer's multiple. FIIs have sold 7pp since 2023; DIIs absorbed every share. The gap is either the opportunity or the permanent cigarette tax.

3 · People

Governance grade C+ — credible operators, opaque on pay

  • Ownership. BAT holds a stable, unpledged promoter stake. No insider trades reported, leaving skin-in-the-game at just 4/10.
  • Leadership. All four executive directors are 34-39 year ITC lifers led by Sanjiv Puri (IIT Kanpur, Wharton). Deep expertise but zero external talent at the top.
  • Red flag. Executive compensation is completely undisclosed; the compensation committee is chaired by a former 42-year ITC employee whose independence is questionable.
  • FII signal. Foreign institutions dropped from 43.4% to 36.1% since Mar 2023 — sustained selling that may reflect governance or ESG concerns beyond just cigarettes.
4 · Story

From tobacco cash cow to diversified FMCG play — now facing its sternest policy test

2021-2024: The Transformation. ITC pivoted from crisis mode (COVID) to a deliberate rebuild under the 'ITC Next' strategy — demerging the capital-heavy Hotels business (Jan 2025, ₹15,163 Cr gain), scaling digital infrastructure across 250+ factories via Mission DigiArc, and acquiring organic/health brands (24 Mantra, Mother Sparsh). FMCG margins climbed from 8.9% to 10%. Management credibility scored 8.5/10 on promise delivery.

2025-Present: The Test. An 'unprecedented' cigarette tax hike (Feb 2026) threatens the engine that funds everything. Management warned about this for years — and was proven right. The question now is whether their mitigation playbook (pricing, portfolio premiumisation, illicit-trade advocacy) can hold cigarette volumes within 5% of prior year. The July 2026 Budget will determine if this is a one-off or a structural policy shift.

Pivot condition: if the July Budget spares cigarettes, ITC's transformation story accelerates. If it doesn't, the discount is earned.
5 · Web Intel

Web research still running — external signals pending

  • Pending. Web research synthesis is not yet available; this slide will be updated when research-claude.md is ready.
6 · Risks

Three risks that could break the thesis

  • Cigarette tax escalation. A second steep hike in the Jul 2026 Budget would confirm a structural policy shift, potentially driving 10-15% volume decline and cutting group operating profit 8-12%.
  • FII exodus & BAT overhang. BAT offloaded $1.5B in May 2025 and may sell more; FIIs have shed 7pp with no reversal in sight. If DII flows slow, there is no natural buyer to fill the gap.
  • Governance opacity. Undisclosed executive pay at a ₹3.8L Cr company, combined with a compromised compensation committee, is a structural blind spot for minority shareholders.
7 · What's Next

One earnings print and one Budget decision in the next 90 days

  • May 5-14, 2026. Q4 FY2026 results — first full quarter post-Feb tax hike. Market will fixate on cigarette volume decline and whether FMCG margins held at 10%.
  • May-Jun 2026. Sproutlife Foods integration signals — acquired Apr 1, early read on how ITC absorbs health/organic brands into its FMCG machine.
  • Jul 2026. Union Budget FY2027 — the single most important event. A second steep cigarette tax hike would break the volume recovery thesis; no hike would be a major positive.
  • H1 FY2027. BAT stake trajectory — further block deals create supply overhang; stabilization removes a persistent weight on the stock.
The July 2026 Budget is the binary event — it either validates the valuation gap or cements it.
8 · For & Against

Lean cautiously constructive — but timing is wrong to act with conviction

  • For. Valuation gap is concrete: 18.6x P/E vs 42-79x peers at comparable ROCE — even a move to 24x delivers 30%+ upside before dividends.
  • For. FMCG margin trajectory proved management right: 8.9% to 10.0% over three quarters, credibility score 9/10 on this specific promise.
  • For. 4.75% dividend yield on ₹15,500 Cr annual FCF and a net-cash balance sheet — the stock pays you to wait for re-rating.
  • Against. Feb 2026 cigarette tax hike may be structural; a repeat in Jul would kill volume recovery and cut group operating profit 8-12%.
  • Against. FII selling is relentless (43.4% to 36.1%) with BAT potentially dumping more — the ownership base is shrinking, not expanding.
  • Against. Governance opacity (undisclosed pay, compromised comp committee, zero insider trades) is a meaningful blind spot at a capital-allocation story.
My View — The fundamentals lean bullish but the calendar leans cautious. The FII selling trend plus governance opacity tip the scale to 'wait'. If Q4 cigarette volumes hold within 5% and the July Budget passes clean, the valuation gap becomes very hard to ignore.

Watchlist to re-rate: Q4 FY2026 cigarette volume data, July 2026 Budget cigarette tax decision, BAT block deal activity